UBS faces $16bn Swiss capital burden as Morgan Stanley merger talk grows
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- MS Morgan Stanley-3.9% 30d
Named in this report.
Indirectly affected
- EWL iShares MSCI Switzerland ETF
iShares MSCI Switzerland ETF holds stocks listed in Switzerland, which this story is about (“swiss”).
- NVS Novartis AG-4.2% 7d
Novartis AG (pharmaceutical preparations) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
- CB Chubb+11.2% 30d
Chubb (fire, marine and casualty insurance) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
- BG Bunge Global-6.3% 30d
Bunge Global (fats and oils) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
- ONON On Holding AG+21.9% 19d
On Holding AG (rubber and plastics footwear) is one of the largest Switzerland-based companies traded in the US, so news about Switzerland (“swiss”) reaches its shares.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MS | +0.66% | +2.30% | base | +0.19% | +4.43% | -1.77% | -2.33% |
| EWL | -2.50% | -1.35% | base | -1.07% | +2.37% | +0.66% | -0.62% |
| NVS | -2.88% | -0.25% | base | -1.37% | +2.20% | +0.20% | +0.73% |
| CB | -3.47% | -1.83% | base | -0.70% | +1.41% | +0.73% | -1.06% |
| BG | +7.52% | +1.81% | base | +0.53% | +2.83% | +4.57% | +5.21% |
| ONON | -9.48% | -7.71% | base | +2.87% | +8.62% | +5.66% | +5.09% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
UBS faces $16bn Swiss capital burden as Morgan Stanley merger talk grows Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| BG | that day | +0.53% | final price |
| BG | the next day | +2.83% | final price |
| BG | two days later | +4.57% | final price |
| BG | three days later | +5.21% | final price |
| BG | three days earlier | +1.81% | final price |
| BG | five days earlier | +7.52% | final price |
| CB | that day | -0.70% | final price |
| CB | the next day | +1.41% | final price |
| CB | two days later | +0.73% | final price |
| CB | three days later | -1.06% | final price |
| CB | three days earlier | -1.83% | final price |
| CB | five days earlier | -3.47% | final price |
| EWL | that day | -1.07% | final price |
| EWL | the next day | +2.37% | final price |
| EWL | two days later | +0.66% | final price |
| EWL | three days later | -0.62% | final price |
| EWL | three days earlier | -1.35% | final price |
| EWL | five days earlier | -2.50% | final price |
| MS | that day | +0.19% | final price |
| MS | the next day | +4.43% | final price |
| MS | two days later | -1.77% | final price |
| MS | three days later | -2.33% | final price |
| MS | three days earlier | +2.30% | final price |
| MS | five days earlier | +0.66% | final price |
| NVS | that day | -1.37% | final price |
| NVS | the next day | +2.20% | final price |
| NVS | two days later | +0.20% | final price |
| NVS | three days later | +0.73% | final price |
| NVS | three days earlier | -0.25% | final price |
| NVS | five days earlier | -2.88% | final price |
| ONON | that day | +2.87% | final price |
| ONON | the next day | +8.62% | final price |
| ONON | two days later | +5.66% | final price |
| ONON | three days later | +5.09% | final price |
| ONON | three days earlier | -7.71% | final price |
| ONON | five days earlier | -9.48% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 68 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Chubb (CB), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Chubb (CB) (jointly held), worth $1,001 - $15,000 on 23 Sep 2026. That is 41 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Chubb (CB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“UBS faces $16bn Swiss capital burden as Morgan Stanley merger talk grows” scores 12 out of 100. The score uses 1 sources.